Ampio Pharmaceuticals inc (AMPE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMPE Annual Balance Sheets →
This page allows investors to track Ampio Pharmaceuticals inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent4.09
Cash & Short-term Investments4.00
Other Current Assets0.92
Prepaid Expense And Other Assets Current0.73
Total Current Assets5.74
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Total Assets5.74
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.10
Total Current Liabilities2.38
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Asset Retirement Obligations, Noncurrent AS0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.27
Total Liabilities2.38
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock245.89
Retained Earnings / Accumulated Deficit-242.53
Other Equity0.00
Common Stockholder's Equity3.36
Total Stockholder's Equity3.36
Liabilities & Stockholder's Equity5.74
4 historic quarters locked

Sign in to unlock the full Ampio Pharmaceuticals inc balance sheet history.

About Ampio Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-24-004090

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.